ANDA 91465, held by Caplin Steriles. Dexmedetomidine Hydrochloride.
As of Nov 22, 2026, ANDA 91465 (Dexmedetomidine Hydrochloride), held by Caplin Steriles, was first approved by FDA on Jun 14, 2016, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 14, 2016 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dexmedetomidine HydrochlorideEQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) · injectable;injection | Dexmedetomidine Hydrochloride | Discontinued |
| Jun 22, 2020 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jun 14, 2016 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters